Dodecakis(carbon dioxide);[(Z)-1-[4-(2,4-dihexoxyphenyl)-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]-3-iminobut-1-enyl]azanide;hydroxymethoxymethoxymethanol;4-[3-(methoxymethyl)thiophen-2-yl]-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;4-(2-methylphenyl)-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;bis(4-(3-pentadecylthiophen-2-yl)-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);5-(3-pentadecylthiophen-2-yl)-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;pentakis(2-(6-pyridin-2-yl-2-pyridinyl)pyridine-4-carboxylic acid);2-(6-pyridin-2-yl-2-pyridinyl)-1,3,5-triazine;hexakis(ruthenium(2+));pentaisothiocyanate
C259H243F18N45O41Ru6S9 — CID 159827543
Data last refreshed: (MolForge compound catalog, from PubChem)
About Dodecakis(carbon dioxide);[(Z)-1-[4-(2,4-dihexoxyphenyl)-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]-3-iminobut-1-enyl]azanide;hydroxymethoxymethoxymethanol;4-[3-(methoxymethyl)thiophen-2-yl]-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;4-(2-methylphenyl)-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;bis(4-(3-pentadecylthiophen-2-yl)-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);5-(3-pentadecylthiophen-2-yl)-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;pentakis(2-(6-pyridin-2-yl-2-pyridinyl)pyridine-4-carboxylic acid);2-(6-pyridin-2-yl-2-pyridinyl)-1,3,5-triazine;hexakis(ruthenium(2+));pentaisothiocyanate
Dodecakis(carbon dioxide);[(Z)-1-[4-(2,4-dihexoxyphenyl)-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]-3-iminobut-1-enyl]azanide;hydroxymethoxymethoxymethanol;4-[3-(methoxymethyl)thiophen-2-yl]-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;4-(2-methylphenyl)-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;bis(4-(3-pentadecylthiophen-2-yl)-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);5-(3-pentadecylthiophen-2-yl)-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;pentakis(2-(6-pyridin-2-yl-2-pyridinyl)pyridine-4-carboxylic acid);2-(6-pyridin-2-yl-2-pyridinyl)-1,3,5-triazine;hexakis(ruthenium(2+));pentaisothiocyanate (PubChem CID 159827543) has the molecular formula C259H243F18N45O41Ru6S9 and a molecular weight of 5879.05 g/mol. Its IUPAC name is dodecakis(carbon dioxide);[(Z)-1-[4-(2,4-dihexoxyphenyl)-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]-3-iminobut-1-enyl]azanide;hydroxymethoxymethoxymethanol;4-[3-(methoxymethyl)thiophen-2-yl]-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;4-(2-methylphenyl)-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;bis(4-(3-pentadecylthiophen-2-yl)-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);5-(3-pentadecylthiophen-2-yl)-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;pentakis(2-(6-pyridin-2-yl-2-pyridinyl)pyridine-4-carboxylic acid);2-(6-pyridin-2-yl-2-pyridinyl)-1,3,5-triazine;hexakis(ruthenium(2+));pentaisothiocyanate.
Molecular Properties
| Compound Name | Dodecakis(carbon dioxide);[(Z)-1-[4-(2,4-dihexoxyphenyl)-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]-3-iminobut-1-enyl]azanide;hydroxymethoxymethoxymethanol;4-[3-(methoxymethyl)thiophen-2-yl]-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;4-(2-methylphenyl)-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;bis(4-(3-pentadecylthiophen-2-yl)-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);5-(3-pentadecylthiophen-2-yl)-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;pentakis(2-(6-pyridin-2-yl-2-pyridinyl)pyridine-4-carboxylic acid);2-(6-pyridin-2-yl-2-pyridinyl)-1,3,5-triazine;hexakis(ruthenium(2+));pentaisothiocyanate |
|---|---|
| PubChem CID | 159827543 |
| Molecular Formula | C259H243F18N45O41Ru6S9 |
| Molecular Weight | 5879.05 g/mol |
| Exact Mass | 5879.98 |
| IUPAC Name | dodecakis(carbon dioxide);[(Z)-1-[4-(2,4-dihexoxyphenyl)-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]-3-iminobut-1-enyl]azanide;hydroxymethoxymethoxymethanol;4-[3-(methoxymethyl)thiophen-2-yl]-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;4-(2-methylphenyl)-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;bis(4-(3-pentadecylthiophen-2-yl)-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);5-(3-pentadecylthiophen-2-yl)-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;pentakis(2-(6-pyridin-2-yl-2-pyridinyl)pyridine-4-carboxylic acid);2-(6-pyridin-2-yl-2-pyridinyl)-1,3,5-triazine;hexakis(ruthenium(2+));pentaisothiocyanate |
| SMILES | CCCCCCCCCCCCCCCc1ccsc1-c1ccc(-c2cc(C(F)(F)F)n[n-]2)nc1.CCCCCCCCCCCCCCCc1ccsc1-c1ccnc(-c2cc(C(F)(F)F)n[n-]2)c1.CCCCCCCCCCCCCCCc1ccsc1-c1ccnc(-c2cc(C(F)(F)F)n[n-]2)c1.COCc1ccsc1-c1ccnc(-c2cc(C(F)(F)F)n[n-]2)c1.Cc1ccccc1-c1ccnc(-c2cc(C(F)(F)F)n[n-]2)c1.O=C(O)c1ccnc(-c2cccc(-c3ccccn3)n2)c1.O=C(O)c1ccnc(-c2cccc(-c3ccccn3)n2)c1.O=C(O)c1ccnc(-c2cccc(-c3ccccn3)n2)c1.O=C(O)c1ccnc(-c2cccc(-c3ccccn3)n2)c1.O=C(O)c1ccnc(-c2cccc(-c3ccccn3)n2)c1.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O.OCOCOCO.[H]/N=C(C)/C=C(\[NH-])c1cc(-c2ccc(OCCCCCC)cc2OCCCCCC)cc(-c2cc(C(F)(F)F)n[n-]2)n1.[N-]=C=S.[N-]=C=S.[N-]=C=S.[N-]=C=S.[N-]=C=S.[Ru+2].[Ru+2].[Ru+2].[Ru+2].[Ru+2].[Ru+2].c1ccc(-c2cccc(-c3ncncn3)n2)nc1 |
| InChI | InChI=1S/C31H38F3N5O2.3C28H37F3N3S.C16H11F3N3.5C16H11N3O2.C15H11F3N3OS.C13H9N5.C3H8O4.5CNS.12CO2.6Ru/c1-4-6-8-10-14-40-23-12-13-24(29(19-23)41-15-11-9-7-5-2)22-17-26(25(36)16-21(3)35)37-27(18-22)28-20-30(39-38-28)31(32,33)34;2*1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-22-17-19-35-27(22)23-16-18-32-24(20-23)25-21-26(34-33-25)28(29,30)31;1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-22-18-19-35-27(22)23-16-17-24(32-21-23)25-20-26(34-33-25)28(29,30)31;1-10-4-2-3-5-12(10)11-6-7-20-13(8-11)14-9-15(22-21-14)16(17,18)19;5*20-16(21)11-7-9-18-15(10-11)14-6-3-5-13(19-14)12-4-1-2-8-17-12;1-22-8-10-3-5-23-14(10)9-2-4-19-11(6-9)12-7-13(21-20-12)15(16,17)18;1-2-7-15-10(4-1)11-5-3-6-12(18-11)13-16-8-14-9-17-13;4-1-6-3-7-2-5;17*2-1-3;;;;;;/h12-13,16-20,35-36H,4-11,14-15H2,1-3H3;3*16-21H,2-15H2,1H3;2-9H,1H3;5*1-10H,(H,20,21);2-7H,8H2,1H3;1-9H;4-5H,1-3H2;;;;;;;;;;;;;;;;;;;;;;;/q-2;4*-1;;;;;;-1;;;5*-1;;;;;;;;;;;;;6*+2/b25-16-,35-21+;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;; |
| InChIKey | NNAPHMOHPTVMEC-NHQAMWOUSA-N |
| XLogP | 57.34 |
| TPSA | 1339.02 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 78 |
| Rotatable Bonds | 91 |
| Heavy Atoms | 378 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 5879.05 |
| LogP ≤ 5 | 57.34 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 78 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159827543 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.